What was DuoGenic StemCells Corporation’s price range in the past 12 months?
DuoGenic StemCells Corporation lowest stock price was TWD 8.03 and its highest was TWD 21.50 in the past 12 months.
What is DuoGenic StemCells Corporation’s market cap?
DuoGenic StemCells Corporation’s market cap is TWD 438.00M.
When is DuoGenic StemCells Corporation’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is DuoGenic StemCells Corporation overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does DuoGenic StemCells Corporation pay dividends?
DuoGenic StemCells Corporation does not currently pay dividends.
What is DuoGenic StemCells Corporation’s EPS estimate?
DuoGenic StemCells Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does DuoGenic StemCells Corporation have?
DuoGenic StemCells Corporation has 36,653,000 shares outstanding.
Which hedge fund is a major shareholder of DuoGenic StemCells Corporation?
Currently, no hedge funds are holding shares in TW:7607
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
DuoGenic StemCells Corporation
Duogenic Stemcells Corporation is primarily engaged in the biotechnology and healthcare industries, offering a variety of services. Their core offerings include cell therapy and the development of closed-culture cell systems. The company was established on March 22, 2018, and its main corporate office is situated in Taichung, Taiwan.
Sector
General
Industry
Medical - Specialties
CEO
Chih Yao Lin
Employees
15
Website
www.dgsc.com.tw
Address
Innovation Incubation Center, Taichung City, TX, 402202, TW